Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Hoofnagle, J. H. TI - Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report JO - New Engl. J. Med. PY - 1986/// VL - 315 SP - 1575 EP - 1578 ER - TY - JOUR AU - Lau, D. T. TI - 10-year follow-up after interferon-alpha therapy for chronic hepatitis C JO - Hepatology PY - 1998/// VL - 28 SP - 1121 EP - 1127 M3 - 10.1002/hep.510280430 N1 - 10.1002/hep.510280430 UR - http://dx.doi.org/10.1002/hep.510280430 ER - TY - JOUR AU - Di Bisceglie, A. M. AU - Hoofnagle, J. H. TI - Optimal therapy of hepatitis C JO - Hepatology PY - 2002/// VL - 36 SP - S121 EP - S127 M3 - 10.1053/jhep.2002.36228 N1 - 10.1053/jhep.2002.36228 UR - http://dx.doi.org/10.1053/jhep.2002.36228 ER - TY - JOUR AU - McHutchison, J. G. AU - Poynard, T. TI - Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C JO - Semin. Liver Dis. PY - 1999/// VL - 19 SP - 57 EP - 65 ER - TY - JOUR AU - Glue, P. TI - Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data JO - Clin. Pharmacol. Ther. PY - 2000/// VL - 68 SP - 556 EP - 567 M3 - 10.1067/mcp.2000.110973 N1 - 10.1067/mcp.2000.110973 UR - http://dx.doi.org/10.1067/mcp.2000.110973 ER - TY - JOUR AU - Zeuzem, S. TI - PEGinterferon [alpha]-2a in patients with chronic hepatitis C JO - New Engl. J. Med. PY - 2000/// VL - 343 SP - 1666 EP - 1672 M3 - 10.1056/NEJM200012073432301 N1 - 10.1056/NEJM200012073432301 UR - http://dx.doi.org/10.1056/NEJM200012073432301 ER - TY - JOUR AU - Heathcote, E. J. TI - PEGinterferon [alpha]-2a in patients with chronic hepatitis C and cirrhosis JO - New Engl. J. Med. PY - 2000/// VL - 343 SP - 1673 EP - 1680 M3 - 10.1056/NEJM200012073432302 N1 - 10.1056/NEJM200012073432302 UR - http://dx.doi.org/10.1056/NEJM200012073432302 ER - TY - JOUR AU - Lindsay, K. L. TI - A randomized, double-blind trial comparing PEGylated interferon alfa-2b to interferon [alpha]-2b as initial treatment for chronic hepatitis C JO - Hepatology PY - 2001/// VL - 34 SP - 395 EP - 403 M3 - 10.1053/jhep.2001.26371 N1 - 10.1053/jhep.2001.26371 UR - http://dx.doi.org/10.1053/jhep.2001.26371 ER - TY - JOUR AU - Manns, M. P. TI - PEGinterferon [alpha]-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial JO - Lancet PY - 2001/// VL - 358 SP - 958 EP - 965 M3 - 10.1016/S0140-6736(01)06102-5 N1 - 10.1016/S0140-6736(01)06102-5 UR - http://dx.doi.org/10.1016/S0140-6736(01)06102-5 ER - TY - JOUR AU - Fried, M. W. TI - PEGinterferon [alpha]-2a plus ribavirin for chronic hepatitis C virus infection JO - New Engl. J. Med. PY - 2002/// VL - 347 SP - 975 EP - 982 M3 - 10.1056/NEJMoa020047 N1 - 10.1056/NEJMoa020047 UR - http://dx.doi.org/10.1056/NEJMoa020047 ER - TY - JOUR AU - Hadziyannis, S. J. TI - PEGinterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose JO - Ann. Intern. Med. PY - 2004/// VL - 140 SP - 346 EP - 355 ER - TY - JOUR AU - Strader, D. B. TI - Understudied populations with hepatitis C JO - Hepatology PY - 2002/// VL - 36 SP - S226 EP - S236 M3 - 10.1053/jhep.2002.36991 N1 - 10.1053/jhep.2002.36991 UR - http://dx.doi.org/10.1053/jhep.2002.36991 ER - TY - JOUR AU - Marcellin, P. TI - Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy JO - Ann. Intern. Med. PY - 1997/// VL - 127 SP - 875 EP - 881 ER - TY - JOUR AU - Shiffman, M. L. TI - Retreatment of patients with chronic hepatitis C JO - Hepatology PY - 2002/// VL - 36 SP - S128 EP - S134 M3 - 10.1053/jhep.2002.36816 N1 - 10.1053/jhep.2002.36816 UR - http://dx.doi.org/10.1053/jhep.2002.36816 ER - TY - JOUR AU - Neumann, A. U. TI - Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-[alpha] therapy JO - Science PY - 1998/// VL - 282 SP - 103 EP - 107 M3 - 10.1126/science.282.5386.103 N1 - 10.1126/science.282.5386.103 UR - http://dx.doi.org/10.1126/science.282.5386.103 ER - TY - JOUR AU - Layden, J. E. AU - Layden, T. J. TI - Viral kinetics of hepatitis C: new insights and remaining limitations JO - Hepatology PY - 2002/// VL - 35 SP - 967 EP - 970 M3 - 10.1053/jhep.2002.32711 N1 - 10.1053/jhep.2002.32711 UR - http://dx.doi.org/10.1053/jhep.2002.32711 ER - TY - JOUR AU - Lau, J. Y. TI - Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group JO - Ann. Intern. Med. PY - 1996/// VL - 124 SP - 868 EP - 876 ER - TY - JOUR AU - Muir, A. J. AU - Bornstein, J. D. AU - Killenberg, P. G. TI - PEGinterferon [alpha]-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites JO - New Engl. J. Med. PY - 2004/// VL - 350 SP - 2265 EP - 2271 M3 - 10.1056/NEJMoa032502 N1 - 10.1056/NEJMoa032502 UR - http://dx.doi.org/10.1056/NEJMoa032502 ER - TY - JOUR AU - Jaeckel, E. TI - Treatment of acute hepatitis C with interferon [alpha]-2b JO - New Engl. J. Med. PY - 2001/// VL - 345 SP - 1452 EP - 1457 M3 - 10.1056/NEJMoa011232 N1 - 10.1056/NEJMoa011232 UR - http://dx.doi.org/10.1056/NEJMoa011232 ER - TY - JOUR AU - Santantonio, T. TI - Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance JO - J. Hepatol. PY - 2005/// VL - 42 SP - 329 EP - 333 M3 - 10.1016/j.jhep.2004.11.021 N1 - 10.1016/j.jhep.2004.11.021 UR - http://dx.doi.org/10.1016/j.jhep.2004.11.021 ER - TY - JOUR AU - Bekisz, J. AU - Schmeisser, H. AU - Hernandez, J. AU - Goldman, N. D. AU - Zoon, K. C. TI - Human interferons alpha, beta and omega JO - Growth Factors PY - 2004/// VL - 22 SP - 243 EP - 251 M3 - 10.1080/08977190400000833 N1 - 10.1080/08977190400000833 UR - http://dx.doi.org/10.1080/08977190400000833 ER - TY - JOUR AU - Sen, G. C. TI - Viruses and interferons JO - Annu. Rev. Microbiol. PY - 2001/// VL - 55 SP - 255 EP - 281 M3 - 10.1146/annurev.micro.55.1.255 N1 - 10.1146/annurev.micro.55.1.255 UR - http://dx.doi.org/10.1146/annurev.micro.55.1.255 ER - TY - JOUR AU - Robek, M. D. AU - Boyd, B. S. AU - Chisari, F. V. TI - Lambda interferon inhibits hepatitis B and C virus replication JO - J. Virol. PY - 2005/// VL - 79 SP - 3851 EP - 3854 M3 - 10.1128/JVI.79.6.3851-3854.2005 N1 - 10.1128/JVI.79.6.3851-3854.2005 UR - http://dx.doi.org/10.1128/JVI.79.6.3851-3854.2005 ER - TY - JOUR AU - Frese, M. TI - Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs JO - Hepatology PY - 2002/// VL - 35 SP - 694 EP - 703 M3 - 10.1053/jhep.2002.31770 N1 - 10.1053/jhep.2002.31770 UR - http://dx.doi.org/10.1053/jhep.2002.31770 ER - TY - JOUR AU - Soza, A. TI - Pilot study of interferon gamma for chronic hepatitis C JO - J. Hepatol. PY - 2005/// VL - 43 SP - 67 EP - 71 M3 - 10.1016/j.jhep.2005.02.023 N1 - 10.1016/j.jhep.2005.02.023 UR - http://dx.doi.org/10.1016/j.jhep.2005.02.023 ER - TY - JOUR AU - Gilmour, K. C. AU - Reich, N. C. TI - Signal transduction and activation of gene transcription by interferons JO - Gene Expr. PY - 1995/// VL - 5 SP - 1 EP - 18 ER - TY - JOUR AU - Gale, M. TI - Effector genes of interferon action against hepatitis C virus JO - Hepatology PY - 2003/// VL - 37 SP - 975 EP - 978 M3 - 10.1053/jhep.2003.50201 N1 - 10.1053/jhep.2003.50201 UR - http://dx.doi.org/10.1053/jhep.2003.50201 ER - TY - JOUR AU - de Veer, M. J. TI - Functional classification of interferon-stimulated genes identified using microarrays JO - J. Leukocyte Biol. PY - 2001/// VL - 69 SP - 912 EP - 920 ER - TY - JOUR AU - Lanford, R. E. TI - Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons JO - J. Virol. PY - 2003/// VL - 77 SP - 1092 EP - 1104 M3 - 10.1128/JVI.77.2.1092-1104.2003 N1 - 10.1128/JVI.77.2.1092-1104.2003 UR - http://dx.doi.org/10.1128/JVI.77.2.1092-1104.2003 ER - TY - JOUR AU - Sumpter, R. TI - Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I JO - J. Virol. PY - 2005/// VL - 79 SP - 2689 EP - 2699 M3 - 10.1128/JVI.79.5.2689-2699.2005 N1 - 10.1128/JVI.79.5.2689-2699.2005 UR - http://dx.doi.org/10.1128/JVI.79.5.2689-2699.2005 ER - TY - JOUR AU - Blight, K. J. AU - Kolykhalov, A. A. AU - Rice, C. M. TI - Efficient initiation of HCV RNA replication in cell culture JO - Science PY - 2000/// VL - 290 SP - 1972 EP - 1974 M3 - 10.1126/science.290.5498.1972 N1 - 10.1126/science.290.5498.1972 UR - http://dx.doi.org/10.1126/science.290.5498.1972 ER - TY - JOUR AU - Guo, J. T. AU - Bichko, V. V. AU - Seeger, C. TI - Effect of alpha interferon on the hepatitis C virus replicon JO - J. Virol. PY - 2001/// VL - 75 SP - 8516 EP - 8523 M3 - 10.1128/JVI.75.18.8516-8523.2001 N1 - 10.1128/JVI.75.18.8516-8523.2001 UR - http://dx.doi.org/10.1128/JVI.75.18.8516-8523.2001 ER - TY - JOUR AU - Abe, K. TI - cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells JO - Virus Res. PY - 2005/// VL - 107 SP - 73 EP - 81 M3 - 10.1016/j.virusres.2004.06.013 N1 - 10.1016/j.virusres.2004.06.013 UR - http://dx.doi.org/10.1016/j.virusres.2004.06.013 ER - TY - JOUR AU - Zhu, H. TI - Gene expression associated with interferon [alpha] antiviral activity in an HCV replicon cell line JO - Hepatology PY - 2003/// VL - 37 SP - 1180 EP - 1188 M3 - 10.1053/jhep.2003.50184 N1 - 10.1053/jhep.2003.50184 UR - http://dx.doi.org/10.1053/jhep.2003.50184 ER - TY - JOUR AU - Guo, J. T. AU - Sohn, J. A. AU - Zhu, Q. AU - Seeger, C. TI - Mechanism of the interferon alpha response against hepatitis C virus replicons JO - Virology PY - 2004/// VL - 325 SP - 71 EP - 81 M3 - 10.1016/j.virol.2004.04.031 N1 - 10.1016/j.virol.2004.04.031 UR - http://dx.doi.org/10.1016/j.virol.2004.04.031 ER - TY - JOUR AU - Bigger, C. B. TI - Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees JO - J. Virol. PY - 2004/// VL - 78 SP - 13779 EP - 13792 M3 - 10.1128/JVI.78.24.13779-13792.2004 N1 - 10.1128/JVI.78.24.13779-13792.2004 UR - http://dx.doi.org/10.1128/JVI.78.24.13779-13792.2004 ER - TY - JOUR AU - Bigger, C. B. AU - Brasky, K. M. AU - Lanford, R. E. TI - DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection JO - J. Virol. PY - 2001/// VL - 75 SP - 7059 EP - 7066 M3 - 10.1128/JVI.75.15.7059-7066.2001 N1 - 10.1128/JVI.75.15.7059-7066.2001 UR - http://dx.doi.org/10.1128/JVI.75.15.7059-7066.2001 ER - TY - JOUR AU - Su, A. I. TI - Genomic analysis of the host response to hepatitis C virus infection JO - Proc. Natl Acad. Sci. USA PY - 2002/// VL - 99 SP - 15669 EP - 15674 M3 - 10.1073/pnas.202608199 N1 - 10.1073/pnas.202608199 UR - http://dx.doi.org/10.1073/pnas.202608199 ER - TY - JOUR AU - Ji, X. TI - Interferon [alpha] regulated gene expression in patients initiating interferon treatment for chronic hepatitis C JO - Hepatology PY - 2003/// VL - 37 SP - 610 EP - 621 M3 - 10.1053/jhep.2003.50105 N1 - 10.1053/jhep.2003.50105 UR - http://dx.doi.org/10.1053/jhep.2003.50105 ER - TY - JOUR AU - Chen, L. TI - Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection JO - Gastroenterology PY - 2005/// VL - 128 SP - 1437 EP - 1444 M3 - 10.1053/j.gastro.2005.01.059 N1 - 10.1053/j.gastro.2005.01.059 UR - http://dx.doi.org/10.1053/j.gastro.2005.01.059 ER - TY - JOUR AU - Enomoto, N. TI - Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection JO - New Engl. J. Med. PY - 1996/// VL - 334 SP - 77 EP - 81 M3 - 10.1056/NEJM199601113340203 N1 - 10.1056/NEJM199601113340203 UR - http://dx.doi.org/10.1056/NEJM199601113340203 ER - TY - JOUR AU - Herion, D. AU - Hoofnagle, J. H. TI - The interferon sensitivity determining region: all hepatitis C virus isolates are not the same JO - Hepatology PY - 1997/// VL - 25 SP - 769 EP - 771 M3 - 10.1002/hep.510250346 N1 - 10.1002/hep.510250346 UR - http://dx.doi.org/10.1002/hep.510250346 ER - TY - JOUR AU - Gale, M. J. TI - Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein JO - Virology PY - 1997/// VL - 230 SP - 217 EP - 227 M3 - 10.1006/viro.1997.8493 N1 - 10.1006/viro.1997.8493 UR - http://dx.doi.org/10.1006/viro.1997.8493 ER - TY - JOUR AU - Gale, M. TI - Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation JO - Mol. Cell. Biol. PY - 1998/// VL - 18 SP - 5208 EP - 5218 ER - TY - JOUR AU - Wang, C. TI - Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication JO - J. Virol. PY - 2003/// VL - 77 SP - 3898 EP - 3912 M3 - 10.1128/JVI.77.7.3898-3912.2003 N1 - 10.1128/JVI.77.7.3898-3912.2003 UR - http://dx.doi.org/10.1128/JVI.77.7.3898-3912.2003 ER - TY - JOUR AU - Khabar, K. S. TI - The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha JO - J. Exp. Med. PY - 1997/// VL - 186 SP - 1077 EP - 1085 M3 - 10.1084/jem.186.7.1077 N1 - 10.1084/jem.186.7.1077 UR - http://dx.doi.org/10.1084/jem.186.7.1077 ER - TY - JOUR AU - Polyak, S. J. TI - Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response JO - J. Virol. PY - 2001/// VL - 75 SP - 6095 EP - 6106 M3 - 10.1128/JVI.75.13.6095-6106.2001 N1 - 10.1128/JVI.75.13.6095-6106.2001 UR - http://dx.doi.org/10.1128/JVI.75.13.6095-6106.2001 ER - TY - JOUR AU - Girard, S. TI - An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis JO - Virology PY - 2002/// VL - 295 SP - 272 EP - 283 M3 - 10.1006/viro.2002.1373 N1 - 10.1006/viro.2002.1373 UR - http://dx.doi.org/10.1006/viro.2002.1373 ER - TY - JOUR AU - Polyak, S. J. AU - Khabar, K. S. AU - Rezeiq, M. AU - Gretch, D. R. TI - Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy JO - J. Virol. PY - 2001/// VL - 75 SP - 6209 EP - 6211 M3 - 10.1128/JVI.75.13.6209-6211.2001 N1 - 10.1128/JVI.75.13.6209-6211.2001 UR - http://dx.doi.org/10.1128/JVI.75.13.6209-6211.2001 ER - TY - JOUR AU - Taylor, D. R. AU - Shi, S. T. AU - Romano, P. R. AU - Barber, G. N. AU - Lai, M. M. TI - Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein JO - Science PY - 1999/// VL - 285 SP - 107 EP - 110 M3 - 10.1126/science.285.5424.107 N1 - 10.1126/science.285.5424.107 UR - http://dx.doi.org/10.1126/science.285.5424.107 ER - TY - JOUR AU - Pavio, N. AU - Taylor, D. R. AU - Lai, M. M. TI - Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR JO - J. Virol. PY - 2002/// VL - 76 SP - 1265 EP - 1272 ER - TY - JOUR AU - Foy, E. TI - Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease JO - Science PY - 2003/// VL - 300 SP - 1145 EP - 1148 M3 - 10.1126/science.1082604 N1 - 10.1126/science.1082604 UR - http://dx.doi.org/10.1126/science.1082604 ER - TY - JOUR AU - Foy, E. TI - Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling JO - Proc. Natl Acad. Sci. USA PY - 2005/// VL - 102 SP - 2986 EP - 2991 M3 - 10.1073/pnas.0408707102 N1 - 10.1073/pnas.0408707102 UR - http://dx.doi.org/10.1073/pnas.0408707102 ER - TY - JOUR AU - Frese, M. AU - Pietschmann, T. AU - Moradpour, D. AU - Haller, O. AU - Bartenschlager, R. TI - Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway JO - J. Gen. Virol. PY - 2001/// VL - 82 SP - 723 EP - 733 ER - TY - JOUR AU - Blindenbacher, A. TI - Expression of hepatitis C virus proteins inhibits interferon alpha signaling in the liver of transgenic mice JO - Gastroenterology PY - 2003/// VL - 124 SP - 1465 EP - 1475 M3 - 10.1016/S0016-5085(03)00290-7 N1 - 10.1016/S0016-5085(03)00290-7 UR - http://dx.doi.org/10.1016/S0016-5085(03)00290-7 ER - TY - JOUR AU - Basu, A. AU - Meyer, K. AU - Ray, R. B. AU - Ray, R. TI - Hepatitis C virus core protein modulates the interferon-induced transacting factors of JAK/STAT signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene JO - Virology PY - 2001/// VL - 288 SP - 379 EP - 390 M3 - 10.1006/viro.2001.1100 N1 - 10.1006/viro.2001.1100 UR - http://dx.doi.org/10.1006/viro.2001.1100 ER - TY - JOUR AU - Heim, M. H. AU - Moradpour, D. AU - Blum, H. E. TI - Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway JO - J. Virol. PY - 1999/// VL - 73 SP - 8469 EP - 8575 ER - TY - JOUR AU - Honda, M. AU - Shimazaki, T. AU - Kaneko, S. TI - La protein is a potent regulator of replication of hepatitis C virus in patients with chronic hepatitis C through internal ribosomal entry site-directed translation JO - Gastroenterology PY - 2005/// VL - 128 SP - 449 EP - 462 M3 - 10.1053/j.gastro.2004.11.064 N1 - 10.1053/j.gastro.2004.11.064 UR - http://dx.doi.org/10.1053/j.gastro.2004.11.064 ER - TY - JOUR AU - Katze, M. G. AU - He, Y. AU - Gale, M. TI - Viruses and interferon: a fight for supremacy JO - Nature Rev. Immunol. PY - 2002/// VL - 2 SP - 675 EP - 687 M3 - 10.1038/nri888 N1 - 10.1038/nri888 UR - http://dx.doi.org/10.1038/nri888 ER - TY - JOUR AU - Taylor, D. R. TI - Hepatitis C virus: evasion of the interferon-induced antiviral response JO - J. Mol. Med. PY - 2000/// VL - 78 SP - 182 EP - 190 M3 - 10.1007/s001090000100 N1 - 10.1007/s001090000100 UR - http://dx.doi.org/10.1007/s001090000100 ER - TY - JOUR AU - Tilg, H. TI - New insights into the mechanisms of interferon [alpha]: an immunoregulatory and anti-inflammatory cytokine JO - Gastroenterology PY - 1997/// VL - 112 SP - 1017 EP - 1021 M3 - 10.1053/gast.1997.v112.pm9041265 N1 - 10.1053/gast.1997.v112.pm9041265 UR - http://dx.doi.org/10.1053/gast.1997.v112.pm9041265 ER - TY - JOUR AU - Lechner, F. TI - Analysis of successful immune responses in persons infected with hepatitis C virus JO - J. Exp. Med. PY - 2000/// VL - 191 SP - 1499 EP - 1512 M3 - 10.1084/jem.191.9.1499 N1 - 10.1084/jem.191.9.1499 UR - http://dx.doi.org/10.1084/jem.191.9.1499 ER - TY - JOUR AU - Kamal, S. M. TI - PEGylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics JO - Hepatology PY - 2004/// VL - 39 SP - 1721 EP - 1731 M3 - 10.1002/hep.20266 N1 - 10.1002/hep.20266 UR - http://dx.doi.org/10.1002/hep.20266 ER - TY - JOUR AU - Rahman, F. TI - Effects of antiviral therapy on the cellular immune response in acute hepatitis C JO - Hepatology PY - 2004/// VL - 40 SP - 87 EP - 97 M3 - 10.1002/hep.20253 N1 - 10.1002/hep.20253 UR - http://dx.doi.org/10.1002/hep.20253 ER - TY - JOUR AU - Kamal, S. M. AU - Fehr, J. AU - Roesler, B. AU - Peters, T. AU - Rasenack, J. W. TI - PEGinterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C JO - Gastroenterology PY - 2002/// VL - 123 SP - 1070 EP - 1083 M3 - 10.1053/gast.2002.36045 N1 - 10.1053/gast.2002.36045 UR - http://dx.doi.org/10.1053/gast.2002.36045 ER - TY - JOUR AU - Rehermann, B. AU - Nascimbeni, M. TI - Immunology of hepatitis B virus and hepatitis C virus infection JO - Nature Rev. Immunol. PY - 2005/// VL - 5 SP - 215 EP - 229 M3 - 10.1038/nri1573 N1 - 10.1038/nri1573 UR - http://dx.doi.org/10.1038/nri1573 ER - TY - JOUR AU - Thomson, M. TI - The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity JO - J. Virol. PY - 2003/// VL - 77 SP - 862 EP - 870 M3 - 10.1128/JVI.77.2.862-870.2003 N1 - 10.1128/JVI.77.2.862-870.2003 UR - http://dx.doi.org/10.1128/JVI.77.2.862-870.2003 ER - TY - JOUR AU - Di Bisceglie, A. M. TI - Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial JO - Ann. Intern. Med. PY - 1995/// VL - 123 SP - 897 EP - 903 ER - TY - JOUR AU - Hoofnagle, J. H. AU - Lau, D. AU - Conjeevaram, H. AU - Kleiner, D. AU - Di Bisceglie, A. M. TI - Prolonged therapy of chronic hepatitis C with ribavirin JO - J. Viral Hepat. PY - 1996/// VL - 3 SP - 247 EP - 252 ER - TY - JOUR AU - Pawlotsky, J. M. TI - Antiviral action of ribavirin in chronic hepatitis C JO - Gastroenterology PY - 2004/// VL - 126 SP - 703 EP - 714 M3 - 10.1053/j.gastro.2003.12.002 N1 - 10.1053/j.gastro.2003.12.002 UR - http://dx.doi.org/10.1053/j.gastro.2003.12.002 ER - TY - JOUR AU - Lindahl, K. AU - Stahle, L. AU - Bruchfeld, A. AU - Schvarcz, R. TI - High-dose ribavirin in combination with standard dose PEGinterferon for treatment of patients with chronic hepatitis C JO - Hepatology PY - 2005/// VL - 41 SP - 275 EP - 279 M3 - 10.1002/hep.20563 N1 - 10.1002/hep.20563 UR - http://dx.doi.org/10.1002/hep.20563 ER - TY - JOUR AU - Lau, J. Y. AU - Tam, R. C. AU - Liang, T. J. AU - Hong, Z. TI - Mechanism of action of ribavirin in the combination treatment of chronic HCV infection JO - Hepatology PY - 2002/// VL - 35 SP - 1002 EP - 1009 M3 - 10.1053/jhep.2002.32672 N1 - 10.1053/jhep.2002.32672 UR - http://dx.doi.org/10.1053/jhep.2002.32672 ER - TY - JOUR AU - Maag, D. AU - Castro, C. AU - Hong, Z. AU - Cameron, C. E. TI - Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin JO - J. Biol. Chem. PY - 2001/// VL - 276 SP - 46094 EP - 46098 M3 - 10.1074/jbc.C100349200 N1 - 10.1074/jbc.C100349200 UR - http://dx.doi.org/10.1074/jbc.C100349200 ER - TY - JOUR AU - Crotty, S. AU - Cameron, C. E. AU - Andino, R. TI - RNA virus error catastrophe: direct molecular test by using ribavirin JO - Proc. Natl Acad. Sci. USA PY - 2001/// VL - 98 SP - 6895 EP - 6900 M3 - 10.1073/pnas.111085598 N1 - 10.1073/pnas.111085598 UR - http://dx.doi.org/10.1073/pnas.111085598 ER - TY - JOUR AU - Crotty, S. TI - The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen JO - Nature Med. PY - 2000/// VL - 6 SP - 1375 EP - 1379 M3 - 10.1038/82191 N1 - 10.1038/82191 UR - http://dx.doi.org/10.1038/82191 ER - TY - JOUR AU - Zhou, S. AU - Liu, R. AU - Baroudy, B. M. AU - Malcolm, B. A. AU - Reyes, G. R. TI - The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA JO - Virology PY - 2003/// VL - 310 SP - 333 EP - 342 ER - TY - JOUR AU - Contreras, A. M. TI - Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system JO - J. Virol. PY - 2002/// VL - 76 SP - 8505 EP - 8517 M3 - 10.1128/JVI.76.17.8505-8517.2002 N1 - 10.1128/JVI.76.17.8505-8517.2002 UR - http://dx.doi.org/10.1128/JVI.76.17.8505-8517.2002 ER - TY - JOUR AU - Lanford, R. E. TI - Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes JO - J. Virol. PY - 2001/// VL - 75 SP - 8074 EP - 8081 M3 - 10.1128/JVI.75.17.8074-8081.2001 N1 - 10.1128/JVI.75.17.8074-8081.2001 UR - http://dx.doi.org/10.1128/JVI.75.17.8074-8081.2001 ER - TY - JOUR AU - Young, K. C. TI - Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy JO - Hepatology PY - 2003/// VL - 38 SP - 869 EP - 878 M3 - 10.1053/jhep.2003.50445 N1 - 10.1053/jhep.2003.50445 UR - http://dx.doi.org/10.1053/jhep.2003.50445 ER - TY - JOUR AU - Lutchman, G. A. TI - Mutation rate of hepatitis C virus in patients during ribavirin monotherapy JO - Hepatology PY - 2004/// VL - 41 SP - 385A EP - 385A ER - TY - JOUR AU - Layden-Almer, J. E. AU - Ribeiro, R. M. AU - Wiley, T. AU - Perelson, A. S. AU - Layden, T. J. TI - Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin JO - Hepatology PY - 2003/// VL - 37 SP - 1343 EP - 1350 M3 - 10.1053/jhep.2003.50217 N1 - 10.1053/jhep.2003.50217 UR - http://dx.doi.org/10.1053/jhep.2003.50217 ER - TY - JOUR AU - Dixit, N. M. AU - Layden-Almer, J. E. AU - Layden, T. J. AU - Perelson, A. S. TI - Modelling how ribavirin improves interferon response rates in hepatitis C virus infection JO - Nature PY - 2004/// VL - 432 SP - 922 EP - 924 M3 - 10.1038/nature03153 N1 - 10.1038/nature03153 UR - http://dx.doi.org/10.1038/nature03153 ER - TY - JOUR AU - Tam, R. C. TI - Ribavirin polarizes human T cell responses towards a type 1 cytokine profile JO - J. Hepatol. PY - 1999/// VL - 30 SP - 376 EP - 382 M3 - 10.1016/S0168-8278(99)80093-2 N1 - 10.1016/S0168-8278(99)80093-2 UR - http://dx.doi.org/10.1016/S0168-8278(99)80093-2 ER - TY - JOUR AU - Cramp, M. E. TI - Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C JO - Gastroenterology PY - 2000/// VL - 118 SP - 346 EP - 355 ER - TY - JOUR AU - Zhang, Y. TI - Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells JO - J. Virol. PY - 2003/// VL - 77 SP - 5933 EP - 5947 M3 - 10.1128/JVI.77.10.5933-5947.2003 N1 - 10.1128/JVI.77.10.5933-5947.2003 UR - http://dx.doi.org/10.1128/JVI.77.10.5933-5947.2003 ER - TY - JOUR AU - Fiedler, M. A. AU - Wernke-Dollries, K. AU - Stark, J. M. TI - Inhibition of viral replication reverses respiratory syncytial virus-induced NF-kappaB activation and interleukin-8 gene expression in A549 cells JO - J. Virol. PY - 1996/// VL - 70 SP - 9079 EP - 9082 ER - TY - JOUR AU - Wakita, T. TI - Production of infectious hepatitis C virus in tissue culture from a cloned viral genome JO - Nature Med. PY - 2005/// VL - 11 SP - 791 EP - 796 M3 - 10.1038/nm1268 N1 - 10.1038/nm1268 UR - http://dx.doi.org/10.1038/nm1268 ER - TY - JOUR AU - Zhong, J. TI - Robust hepatitis C virus infection in vitro JO - Proc. Natl Acad. Sci. USA PY - 2005/// VL - 102 SP - 9294 EP - 9299 M3 - 10.1073/pnas.0503596102 N1 - 10.1073/pnas.0503596102 UR - http://dx.doi.org/10.1073/pnas.0503596102 ER - TY - JOUR AU - Lindenbach, B. D. TI - Complete replication of hepatitis C virus in cell culture JO - Science PY - 2005/// VL - 309 SP - 623 EP - 626 M3 - 10.1126/science.1114016 N1 - 10.1126/science.1114016 UR - http://dx.doi.org/10.1126/science.1114016 ER - TY - JOUR AU - Reesink, H. W. TI - Initial results of a phase 1B, multiple-dose study of VX-950, a hepatitis C virus protease inhibitor JO - Gastroenterology PY - 2005/// VL - 128 SP - 527A EP - 527A ER - TY - JOUR AU - Rodriguez-Torres, M. TI - Valopicitabine (nm283) alone and in combination with PEG-interferon in patients with genotype 1 chronic hepatitis C: preliminary results from an ongoing phase 1i, multicenter study JO - Gastroenterology PY - 2005/// VL - 128 SP - 695A EP - 695A M3 - 10.1053/j.gastro.2004.12.046 N1 - 10.1053/j.gastro.2004.12.046 UR - http://dx.doi.org/10.1053/j.gastro.2004.12.046 ER -